Sergei I. Kudryashov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sergei I. Kudryashov has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Louise M. Karzakova
I. Ulyanov Chuvash State University
10 shared publications - Nadezhda A. Komelyagina
Chuvash State University
4 shared publications - Nadezhda V. Zhuravleva
Chuvash State University; Chuvashia Med Insurance Company JSC
4 shared publications - Anastasia V. Odintsova
Chuvash State University
3 shared publications - Marina A. Stenina
N.I. Pirogov Russian National Research Medical University
3 shared publications - Olga I. Autonomova
Fresenius Nephroke Dialysis Center
3 shared publications
Latest Publications
- 26 January 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 29 (4)
The role of cytokines in the formation and prediction of refractory neprotic syndrome in membranous nepropathy
BACKGROUND . The lack of reliable methods for predicting the development of treatment-refractory membranous nephropathy (MNP) with nephrotic syndrome (NS) is due to a lack of understanding of the mechanisms of NS resistance to treatment.THE AIM: to study the features of the cytokine status in patients with MNP and their significance in the formation and prediction of refractory NS. PATIENTS AND METHODS . The study was prospective and included a cohort of patients with MPN who were admitted to the nephrology department with active NS and were subsequently followed up for 24 months in the nephrologist's office at the polyclinic. The study endpoint was the completion of the 24-month follow-up period, during which the study group was divided into two subgroups based on their response to treatment: a subgroup of patients with treatment-responsive NS and a subgroup of patients with treatment-refractory NS. At the beginning of treatment and after 24 months, blood and urine samples were collected to determine the levels of cytokines IL-2, IL-4, IL-8, IL-10, and IL-17A, which were stored at -70°C until analysis. The levels of cytokines were determined simultaneously using enzyme-linked immunosorbent assay at the end of treatment. RESULTS . The study included 136 patients with MNP: 98 patients with the debut of NS, 25 with persistent NS, and 13 with frequent NS relapses. After 24 months of follow-up, 78 patients were found to have NS remission. 58 patients were refractory to treatment. In patients with refractory NS, blood and urine samples showed increased baseline levels of pro-inflammatory cytokines IL-8 and IL-17A and decreased levels of IL-10 compared to those in patients who achieved disease remission. CONCLUSION . According to the results of the study, the initial normalized by creatinine levels of IL-8 and IL-17A in the urine can be used as biomarkers for early prediction of refractory NS in MPN
- 26 January 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 29 (4)
The role of cytokines in the formation and prediction of refractory neprotic syndrome in membranous nepropathy
BACKGROUND . The lack of reliable methods for predicting the development of treatment-refractory membranous nephropathy (MNP) with nephrotic syndrome (NS) is due to a lack of understanding of the mechanisms of NS resistance to treatment.THE AIM: to study the features of the cytokine status in patients with MNP and their significance in the formation and prediction of refractory NS. PATIENTS AND METHODS . The study was prospective and included a cohort of patients with MPN who were admitted to the nephrology department with active NS and were subsequently followed up for 24 months in the nephrologist's office at the polyclinic. The study endpoint was the completion of the 24-month follow-up period, during which the study group was divided into two subgroups based on their response to treatment: a subgroup of patients with treatment-responsive NS and a subgroup of patients with treatment-refractory NS. At the beginning of treatment and after 24 months, blood and urine samples were collected to determine the levels of cytokines IL-2, IL-4, IL-8, IL-10, and IL-17A, which were stored at -70°C until analysis. The levels of cytokines were determined simultaneously using enzyme-linked immunosorbent assay at the end of treatment. RESULTS . The study included 136 patients with MNP: 98 patients with the debut of NS, 25 with persistent NS, and 13 with frequent NS relapses. After 24 months of follow-up, 78 patients were found to have NS remission. 58 patients were refractory to treatment. In patients with refractory NS, blood and urine samples showed increased baseline levels of pro-inflammatory cytokines IL-8 and IL-17A and decreased levels of IL-10 compared to those in patients who achieved disease remission. CONCLUSION . According to the results of the study, the initial normalized by creatinine levels of IL-8 and IL-17A in the urine can be used as biomarkers for early prediction of refractory NS in MPN
- 25 December 2025
- Published by ECO-Vector LLC (Publications) in Perm Medical Journal
- Vol. 42 (6)
The importance of immunological monitoring in the treatment of refractory membranous nephropathy: clinical case
Primary membranous nephropathy is the most common morphological variant of glomerulonephritis with nephrotic syndrome in the European ancestry. Immunosuppressive therapy is required in most cases of membranous nephropathy treatment. The choice of immunosuppressive drugs and the determination of therapy duration for this nephropathy cause significant difficulties. The role of monitoring immunological parameters in assessing the effectiveness of immunosuppressive therapy and its duration has been poorly studied. The clinical case report examines modern treatment methods for membranous nephropathy with refractory nephrotic syndrome and demonstrates, using a concrete clinical example, the significance of monitoring immunological parameters during immunosuppressive therapy. A 62-year-old female patient had persistent edema of the lower extremities, as well as high levels of proteinuria and autoantibodies to phospholipase A2 receptor (PLA2R). The diagnosis of stage 2 membranous nephropathy was made based on the morphological findings of the renal biopsy. Initial treatment with corticosteroids resulted only in a short-term improvement. Adding cyclosporine to steroid therapy also failed to achieve stable remission of the disease. Two infusions of rituximab (1 g each) in combination with methylprednisolone (16 mg) led to partial remission of the disease by the fifth month (22 weeks later) after administration of the 2nd dose of rituximab, complete remission was achieved by the sixth month (27 weeks later). By this time, the levels of proteinuria and PLA2R antibodies had significantly decreased. However, monitoring of the B-system immune parameters showed increased urinary excretion of IgG and IgA, depending on the damage to the glomerular filtration barrier, which was the reason for the 3rd infusion of rituximab. Laboratory tests conducted 5 months after the administration of the 3rd dose of rituximab confirmed maintained clinical remission and restoration of immunoglobulin levels to the reference values. This clinical observation confirms that the use of rituximab in combination with methylprednisolone is an effective method of refractory membranous nephropathy treatment. This case report demonstrates the possibility of monitoring urinary IgG and IgA levels normalized to urine creatinine level to assess the effectiveness of rituximab therapy and determine its optimal duration.
- 25 December 2025
- Published by ECO-Vector LLC (Publications) in Perm Medical Journal
- Vol. 42 (6)
The importance of immunological monitoring in the treatment of refractory membranous nephropathy: clinical case
Primary membranous nephropathy is the most common morphological variant of glomerulonephritis with nephrotic syndrome in the European ancestry. Immunosuppressive therapy is required in most cases of membranous nephropathy treatment. The choice of immunosuppressive drugs and the determination of therapy duration for this nephropathy cause significant difficulties. The role of monitoring immunological parameters in assessing the effectiveness of immunosuppressive therapy and its duration has been poorly studied. The clinical case report examines modern treatment methods for membranous nephropathy with refractory nephrotic syndrome and demonstrates, using a concrete clinical example, the significance of monitoring immunological parameters during immunosuppressive therapy. A 62-year-old female patient had persistent edema of the lower extremities, as well as high levels of proteinuria and autoantibodies to phospholipase A2 receptor (PLA2R). The diagnosis of stage 2 membranous nephropathy was made based on the morphological findings of the renal biopsy. Initial treatment with corticosteroids resulted only in a short-term improvement. Adding cyclosporine to steroid therapy also failed to achieve stable remission of the disease. Two infusions of rituximab (1 g each) in combination with methylprednisolone (16 mg) led to partial remission of the disease by the fifth month (22 weeks later) after administration of the 2nd dose of rituximab, complete remission was achieved by the sixth month (27 weeks later). By this time, the levels of proteinuria and PLA2R antibodies had significantly decreased. However, monitoring of the B-system immune parameters showed increased urinary excretion of IgG and IgA, depending on the damage to the glomerular filtration barrier, which was the reason for the 3rd infusion of rituximab. Laboratory tests conducted 5 months after the administration of the 3rd dose of rituximab confirmed maintained clinical remission and restoration of immunoglobulin levels to the reference values. This clinical observation confirms that the use of rituximab in combination with methylprednisolone is an effective method of refractory membranous nephropathy treatment. This case report demonstrates the possibility of monitoring urinary IgG and IgA levels normalized to urine creatinine level to assess the effectiveness of rituximab therapy and determine its optimal duration.
- 25 June 2024
- Published by I.N. Ulianov Chuvash State University in Acta medica Eurasica
- No. 2
CLINICAL AND LABORATORY CHARACTERISTICS OF GLOMERULONEPHRITISES WITH NEPHROTIC SYNDROME IN ADULTS
Glomerulonephritises, manifested by nephrotic syndrome, are common in both children and adults. Clinical and laboratory manifestations of glomerulonephritises with nephrotic syndrome in adults have been poorly studied due to their lower prevalence and difficulty of selecting representative cohorts of subjects. The aim of the study was to study clinical and laboratory features of glomerulonephritises with nephrotic syndrome in adults. Material and methods. A retrospective study of medical histories and outpatient records of patients with primary glomerulonephritises who underwent examination and treatment in the nephrological department and/or nephrological office at the consultative and diagnostic center of the BI "Republican Clinical Hospital" under the Health Ministry of Chuvashia in 2005-2014 was conducted. At this, from the total number of patients with glomerulonephritises, patients with primary glomerulonephritises with nephrotic syndrome belonging to the Chuvash ethnic population were selected for the study group. Clinical and demographic, laboratory and instrumental indicators of the subjects were entered into Excel environment for subsequent statistical data processing in Statistica 10.0 program. Research results. When analyzing the age structure of the onset of glomerulonephritises with nephrotic syndrome, it was found that the disease manifested and was diagnosed most often in the age range of 40-49 years (23% of the subjects), the median age of onset was 41 years. There were 68% of male patients in the cohort of subjects. Membranous nephropathy was found in 39% of patients, focal segmental glomerulosclerosis – in 32%, and the disease with minimal changes – in 23%. Refractory nephrotic syndrome occurs in 31% of patients, arterial hypertension – in 35%, coronary heart disease – in 6.3%, infectious complications – in 8.5%, thromboses or vascular thromboembolism – in 6.7%. Correlations of clinical and laboratory parameters were found, in particular, the rate of nephrotic syndrome recurrence correlated with daily proteinuria (rs = 0.47), serum creatinine level (rs = 0.44), estimated glomerular filtration rate (rs = –0.49). Conclusions. The characteristics was given to clinical and laboratory manifestations and the pathomorphological structure of the group of glomerulonephritises with nephrotic syndrome in the Chuvash population, which generally do not differ from those in the pan-European population.
- 25 June 2024
- Published by I.N. Ulianov Chuvash State University in Acta medica Eurasica
- No. 2
CLINICAL AND LABORATORY CHARACTERISTICS OF GLOMERULONEPHRITISES WITH NEPHROTIC SYNDROME IN ADULTS
Glomerulonephritises, manifested by nephrotic syndrome, are common in both children and adults. Clinical and laboratory manifestations of glomerulonephritises with nephrotic syndrome in adults have been poorly studied due to their lower prevalence and difficulty of selecting representative cohorts of subjects. The aim of the study was to study clinical and laboratory features of glomerulonephritises with nephrotic syndrome in adults. Material and methods. A retrospective study of medical histories and outpatient records of patients with primary glomerulonephritises who underwent examination and treatment in the nephrological department and/or nephrological office at the consultative and diagnostic center of the BI "Republican Clinical Hospital" under the Health Ministry of Chuvashia in 2005-2014 was conducted. At this, from the total number of patients with glomerulonephritises, patients with primary glomerulonephritises with nephrotic syndrome belonging to the Chuvash ethnic population were selected for the study group. Clinical and demographic, laboratory and instrumental indicators of the subjects were entered into Excel environment for subsequent statistical data processing in Statistica 10.0 program. Research results. When analyzing the age structure of the onset of glomerulonephritises with nephrotic syndrome, it was found that the disease manifested and was diagnosed most often in the age range of 40-49 years (23% of the subjects), the median age of onset was 41 years. There were 68% of male patients in the cohort of subjects. Membranous nephropathy was found in 39% of patients, focal segmental glomerulosclerosis – in 32%, and the disease with minimal changes – in 23%. Refractory nephrotic syndrome occurs in 31% of patients, arterial hypertension – in 35%, coronary heart disease – in 6.3%, infectious complications – in 8.5%, thromboses or vascular thromboembolism – in 6.7%. Correlations of clinical and laboratory parameters were found, in particular, the rate of nephrotic syndrome recurrence correlated with daily proteinuria (rs = 0.47), serum creatinine level (rs = 0.44), estimated glomerular filtration rate (rs = –0.49). Conclusions. The characteristics was given to clinical and laboratory manifestations and the pathomorphological structure of the group of glomerulonephritises with nephrotic syndrome in the Chuvash population, which generally do not differ from those in the pan-European population.
- 28 March 2024
- Published by I.N. Ulianov Chuvash State University in Acta medica Eurasica
- No. 1
FEATURES OF THE T-IMMUNE SYSTEM IN PATIENTS WITH GLOMERULONEPHRITISES WITH NEPHROTIC SYNDROME
The study of issues related to glomerulonephritises with nephrotic syndrome is one of the urgent problems of medicine due to their prevalence worldwide, mainly in the young age group. Medical workers distinguish primary (idiopathic) nephrotic syndrome, which occurs in 80–90% of cases, and secondary nephrotic syndrome, mainly associated with systemic autoimmune diseases, diabetes mellitus and neoplasms. Glomerulonephritises, manifested by nephrotic syndrome (membranous nephropathy, focal segmental glomerulosclerosis, nephropathy with minimal changes), are known to be autoimmune diseases. To date, the immunological mechanisms of the pathogenesis of glomerulonephritises with nephrotic syndrome associated with the T-system of adaptive immunity remain unexplored. The aim of the study was to study the role of the T–immune system in the pathogenesis of primary nephrotic syndrome based on the study of immunoregulatory, activated T-cell subsets in patients with this pathology. Material and methods. 136 patients with chronic glomerulonephritis with nephrotic syndrome were selected for the study. The assessment of the T-immune system included determination of the lymphocyte phenotype of immunoregulatory T-cell subsets (T-helper/inducers, cytotoxic T-lymphocytes), various subpopulations of activated T-cells (activated T-lymphocytes; activated T-lymphocytes expressing CD25–alpha chain of IL-2 receptor; activated cytotoxic T-lymphocytes expressing HLA-DR and CD38) and regulatory T-cells (Treg cells). Study results. In the patients of the examined cohort, an increase in the number of T-lymphocytes and T-helper cells, as well as activated T-lymphocytes expressing HLA-DR antigens, was found. At this, the content of cytotoxic T-cells and the number of activated T-cells expressing the IL-2 – CD25 receptor did not differ from similar indicators in healthy individuals. The levels of Treg cells and activated cytotoxic T-lymphocytes with the CD3+CD8brightCD38+ phenotype were reduced. The immunoregulatory index (T-helpers/cytotoxic T-lymphocytes) was increased, due to an increase in the number of T-helper cells against the background of an unchanged number of cytotoxic T-lymphocytes. Conclusions. The results of the study indicate that the main features of the T-system of the immune response in primary nephrotic syndrome are imbalance in the ratio of the content of immunoregulatory cells due to predominance of T-helper cells and a decrease in the number of Treg cells.
- 28 March 2024
- Published by I.N. Ulianov Chuvash State University in Acta medica Eurasica
- No. 1
FEATURES OF THE T-IMMUNE SYSTEM IN PATIENTS WITH GLOMERULONEPHRITISES WITH NEPHROTIC SYNDROME
The study of issues related to glomerulonephritises with nephrotic syndrome is one of the urgent problems of medicine due to their prevalence worldwide, mainly in the young age group. Medical workers distinguish primary (idiopathic) nephrotic syndrome, which occurs in 80–90% of cases, and secondary nephrotic syndrome, mainly associated with systemic autoimmune diseases, diabetes mellitus and neoplasms. Glomerulonephritises, manifested by nephrotic syndrome (membranous nephropathy, focal segmental glomerulosclerosis, nephropathy with minimal changes), are known to be autoimmune diseases. To date, the immunological mechanisms of the pathogenesis of glomerulonephritises with nephrotic syndrome associated with the T-system of adaptive immunity remain unexplored. The aim of the study was to study the role of the T–immune system in the pathogenesis of primary nephrotic syndrome based on the study of immunoregulatory, activated T-cell subsets in patients with this pathology. Material and methods. 136 patients with chronic glomerulonephritis with nephrotic syndrome were selected for the study. The assessment of the T-immune system included determination of the lymphocyte phenotype of immunoregulatory T-cell subsets (T-helper/inducers, cytotoxic T-lymphocytes), various subpopulations of activated T-cells (activated T-lymphocytes; activated T-lymphocytes expressing CD25–alpha chain of IL-2 receptor; activated cytotoxic T-lymphocytes expressing HLA-DR and CD38) and regulatory T-cells (Treg cells). Study results. In the patients of the examined cohort, an increase in the number of T-lymphocytes and T-helper cells, as well as activated T-lymphocytes expressing HLA-DR antigens, was found. At this, the content of cytotoxic T-cells and the number of activated T-cells expressing the IL-2 – CD25 receptor did not differ from similar indicators in healthy individuals. The levels of Treg cells and activated cytotoxic T-lymphocytes with the CD3+CD8brightCD38+ phenotype were reduced. The immunoregulatory index (T-helpers/cytotoxic T-lymphocytes) was increased, due to an increase in the number of T-helper cells against the background of an unchanged number of cytotoxic T-lymphocytes. Conclusions. The results of the study indicate that the main features of the T-system of the immune response in primary nephrotic syndrome are imbalance in the ratio of the content of immunoregulatory cells due to predominance of T-helper cells and a decrease in the number of Treg cells.
- Open Access
- 13 June 2023
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 26 (1) , 181-190
A new approach to immunosuppressive therapy in patients with glomerulonephritis with nephrotic syndrome
Glomerulonephritis (GN) is a group of immuno-inflammatory kidney diseases with predominant glomerular lesions that are difficult to treat. The greatest problems are caused by the treatment of GN with nephrotic syndrome, which often has a recurrent course. The aim of the research was to study the effectiveness of recombinant interleukin-2 (rIL-2) therapy in the GN patients with nephrotic syndrome. 62 patients with a nephrotic form of primary GN with frequent relapses admitted to the Nephrology Department have been recruited into the study. The age of patients was from 18 to 65 years. The patients underwent standard examinations, as well as immunological studies, before administration of the anti-relapse treatment, and 12 months after the treatment was started. Immunological testing included immunophenotyping of lymphocytes with counting of T and B lymphocytes, immunoregulatory and activated subpopulations of T lymphocytes, determination of urinary immunoglobulins (IgM, IgG, IgA) by immunoturbidimetric assays, proinflammatory cytokines – IL-1β, IL-8, IL-17A and anti-inflammatory cytokine IL-10 by ELISA tests. As a result of studies, the examined patients showed an increased contents of T helper cells, activated T lymphocytes (CD8+HLA-DR+CD45+, CD3+CD8brightCD38+) along with decreased numbers of Treg cells and an increased contents of proinflammatory cytokines IL-1β, IL-8, IL-17A and immunoglobulins of all three classes in urinary samples.The cohort of patients with GN selected for the study was divided in two groups (the main group and the comparison group). In addition to nephroprotective and steroid therapy, the treatment regimen of patients included rIL-2 in the main group, or cyclophosphamide in the comparison group. Regardless of the method used, the levels of protein, IgG and IL-17A in the urine proved to be decreased relative to the initial values; the contents of B cells and HLA-DR+ cytotoxic T lymphocytes in peripheral blood were found to be decreased. The revealed changes were more pronounced in the main group of patients. By 12 months after starting the treatment, the mentioned indexes began to differ significantly in the main group from those in the comparison group. Serum creatinine levels, numbers of T helper cells and Treg cells, IL-1β levels in urine did not undergo significant changes in the comparison group, whereas a decrease in serum creatinine and urinary IL-1β was registered in the main group of patients, along with decreased number of T helpers and increased numbers of Treg cells. In the main group of patients treated with rIL-2, the average number of relapses per year decreased by 4 times, showing only a 1.2-fold decrease in the comparison group. Hence, the low-dose therapy with rIL-2 may be considered an effective and safe alternative to conventional immunosuppressive therapy and a new option of the targeted treatment of glomerulonephritis with frequent recurrence of nephrotic syndrome.
- 13 June 2023
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 26 (1) , 181-190
Open AccessA new approach to immunosuppressive therapy in patients with glomerulonephritis with nephrotic syndrome
Glomerulonephritis (GN) is a group of immuno-inflammatory kidney diseases with predominant glomerular lesions that are difficult to treat. The greatest problems are caused by the treatment of GN with nephrotic syndrome, which often has a recurrent course. The aim of the research was to study the effectiveness of recombinant interleukin-2 (rIL-2) therapy in the GN patients with nephrotic syndrome. 62 patients with a nephrotic form of primary GN with frequent relapses admitted to the Nephrology Department have been recruited into the study. The age of patients was from 18 to 65 years. The patients underwent standard examinations, as well as immunological studies, before administration of the anti-relapse treatment, and 12 months after the treatment was started. Immunological testing included immunophenotyping of lymphocytes with counting of T and B lymphocytes, immunoregulatory and activated subpopulations of T lymphocytes, determination of urinary immunoglobulins (IgM, IgG, IgA) by immunoturbidimetric assays, proinflammatory cytokines – IL-1β, IL-8, IL-17A and anti-inflammatory cytokine IL-10 by ELISA tests. As a result of studies, the examined patients showed an increased contents of T helper cells, activated T lymphocytes (CD8+HLA-DR+CD45+, CD3+CD8brightCD38+) along with decreased numbers of Treg cells and an increased contents of proinflammatory cytokines IL-1β, IL-8, IL-17A and immunoglobulins of all three classes in urinary samples.The cohort of patients with GN selected for the study was divided in two groups (the main group and the comparison group). In addition to nephroprotective and steroid therapy, the treatment regimen of patients included rIL-2 in the main group, or cyclophosphamide in the comparison group. Regardless of the method used, the levels of protein, IgG and IL-17A in the urine proved to be decreased relative to the initial values; the contents of B cells and HLA-DR+ cytotoxic T lymphocytes in peripheral blood were found to be decreased. The revealed changes were more pronounced in the main group of patients. By 12 months after starting the treatment, the mentioned indexes began to differ significantly in the main group from those in the comparison group. Serum creatinine levels, numbers of T helper cells and Treg cells, IL-1β levels in urine did not undergo significant changes in the comparison group, whereas a decrease in serum creatinine and urinary IL-1β was registered in the main group of patients, along with decreased number of T helpers and increased numbers of Treg cells. In the main group of patients treated with rIL-2, the average number of relapses per year decreased by 4 times, showing only a 1.2-fold decrease in the comparison group. Hence, the low-dose therapy with rIL-2 may be considered an effective and safe alternative to conventional immunosuppressive therapy and a new option of the targeted treatment of glomerulonephritis with frequent recurrence of nephrotic syndrome.
- 30 March 2023
- Published by I.N. Ulianov Chuvash State University in Acta medica Eurasica
- No. 1
CHARACTERISTICS OF THE IMMUNE STATUS IN PATIENTS WITH DECOMPENSATION OF LIVER CIRRHOSIS
Liver cirrhosis continues to be an acute problem of modern medicine due to the high rates of its prevalence and mortality. The high mortality rate is caused by the development of the number of life–threatening complications in decompensated forms of liver cirrhosis – hepatorenal syndrome, infections and varicose bleeding. Hepatorenal syndrome and infections are the result of immunological shifts occurring during decompensation of liver cirrhosis. Currently available literature data do not allow us to create a complete picture of the functional state of various links of adaptive immunity with decompensated liver cirrhosis. The aim of the research was to study the characteristic features of adaptive immunity in patients with decompensated liver cirrhosis. Material and methods. The prospective cohort study included 136 patients with decompensated liver cirrhosis, who received inpatient treatment in the hepatological department of the multidisciplinary hospital. The cohort of examined patients was divided into two groups, one of which included patients with liver cirrhosis of viral origin (n = 78), the other – patients with alcoholic liver cirrhosis (n = 58). In addition to the generally accepted standard methods, the patient examination program included immunological tests: identification of T- and B-lymphocytes, immunoregulatory and activated subpopulations of T-lymphocytes by the method of immunophenotyping peripheral blood mononuclear cells using monoclonal antibodies. The serum levels of immunoglobulins IgM, IgG, IgA, circulating immune complexes were determined by immunoturbidimetric method. Results. The study of indicators of the humoral link of adaptive immunity revealed an increase in the number of B cells, an increase in IgM, IgG, IgA and circulating immune complexes in patients with decompensated liver cirrhosis. The cellular link of adaptive immunity was characterized by an increase in the relative content of T helper cells, activated T cells against the background of a decrease in the number of immature T cells and T regulatory cells. Conclusions. The distinctive features of adaptive immunity in patients with decompensated liver cirrhosis are simultaneous activation of both humoral and cellular components, which, apparently, supports the systemic inflammatory process and the associated progressive liver fibrosis.
- 30 March 2023
- Published by I.N. Ulianov Chuvash State University in Acta medica Eurasica
- No. 1
CHARACTERISTICS OF THE IMMUNE STATUS IN PATIENTS WITH DECOMPENSATION OF LIVER CIRRHOSIS
Liver cirrhosis continues to be an acute problem of modern medicine due to the high rates of its prevalence and mortality. The high mortality rate is caused by the development of the number of life–threatening complications in decompensated forms of liver cirrhosis – hepatorenal syndrome, infections and varicose bleeding. Hepatorenal syndrome and infections are the result of immunological shifts occurring during decompensation of liver cirrhosis. Currently available literature data do not allow us to create a complete picture of the functional state of various links of adaptive immunity with decompensated liver cirrhosis. The aim of the research was to study the characteristic features of adaptive immunity in patients with decompensated liver cirrhosis. Material and methods. The prospective cohort study included 136 patients with decompensated liver cirrhosis, who received inpatient treatment in the hepatological department of the multidisciplinary hospital. The cohort of examined patients was divided into two groups, one of which included patients with liver cirrhosis of viral origin (n = 78), the other – patients with alcoholic liver cirrhosis (n = 58). In addition to the generally accepted standard methods, the patient examination program included immunological tests: identification of T- and B-lymphocytes, immunoregulatory and activated subpopulations of T-lymphocytes by the method of immunophenotyping peripheral blood mononuclear cells using monoclonal antibodies. The serum levels of immunoglobulins IgM, IgG, IgA, circulating immune complexes were determined by immunoturbidimetric method. Results. The study of indicators of the humoral link of adaptive immunity revealed an increase in the number of B cells, an increase in IgM, IgG, IgA and circulating immune complexes in patients with decompensated liver cirrhosis. The cellular link of adaptive immunity was characterized by an increase in the relative content of T helper cells, activated T cells against the background of a decrease in the number of immature T cells and T regulatory cells. Conclusions. The distinctive features of adaptive immunity in patients with decompensated liver cirrhosis are simultaneous activation of both humoral and cellular components, which, apparently, supports the systemic inflammatory process and the associated progressive liver fibrosis.
- Open Access
- 18 October 2021
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 66 (10) , 610-617
Features of the immunological profile of blood and urine in patients with post-infectious glomerulonephritis
The timely diagnosis and treatment of post-infectious glomerulonephritis (PIGN) is currently limited by the erased and low-symptom nature of the disease, which leads to the search for informative biological markers of the disease, which can be used as immunological indicators of blood and urine. The study was carried out in order to establish the characteristic changes in the immunological parameters of blood and urine in patients with PIGN. The study included 60 patients with PIGN from among the patients, hospitalized in the nephrology department of the Republican Clinical Hospital of Health Care Ministry of the Chuvash Republic in 2015-2018. In addition to the generally accepted research methods, the patients underwent: 1) the determination of indicators of innate and acquired immune response in the blood (CD3+ -, CD3+ CD4+-, CD3+CD8+-, CD4+CD25+-, CD95+-, CD20+-, CD14+CD282+-, CD14+CD284+- cells; levels of IgG, IgA, IgM, circulating immune complexes, C3, C4) and urine (levels of IgG, IgA, IgM, C3, C4); 2) the determination of the levels of cytokines - IL-1β, Ra-IL-1β, IL-2, IL-4, IL-8, IL-10, IL-17A in blood serum and urine. The data obtained were compared with those of the group of healthy individuals. The changes in blood immunological parameters, identified in the group of patients with PIGN, indicate the activation of innate immunity (the increase in the number of CD14+TLR2+- cells) and the humoral component of adaptive immunity (the increase in the number of B-lymphocytes, hyperimmunoglobulinemia - the increase in IgM and IgA levels) against the background of the decrease in the number of T (CD3+) - lymphocytes and regulatory (CD4+CD25high) - cells, hypocomplementemia (decreased levels of C3, C4). The increase in the content of C3, IgG and IgA was found in the urine. The cytokine profile of blood in patients with PIGN was characterized by the increase in the levels of pro- and anti-inflammatory cytokines IL-1β, Ra-IL-1β, IL-2, IL-8, IL-10, IL-17A, with the exception of IL-4, which remained on the levels of healthy individuals. The cytokine profile of urine in patients was characterized by the increase in the levels of pro-inflammatory cytokines IL-1β, IL-2, IL-8, IL-17A and anti-inflammatory cytokine - IL-10, with no changes in the content of Ra-IL-1β and IL-4. The revealed features of the immunological profile of blood and urine in patients with PIGN reflect the immunopathogenetic mechanisms of this disease.
- 18 October 2021
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 66 (10) , 610-617
Open AccessFeatures of the immunological profile of blood and urine in patients with post-infectious glomerulonephritis
The timely diagnosis and treatment of post-infectious glomerulonephritis (PIGN) is currently limited by the erased and low-symptom nature of the disease, which leads to the search for informative biological markers of the disease, which can be used as immunological indicators of blood and urine. The study was carried out in order to establish the characteristic changes in the immunological parameters of blood and urine in patients with PIGN. The study included 60 patients with PIGN from among the patients, hospitalized in the nephrology department of the Republican Clinical Hospital of Health Care Ministry of the Chuvash Republic in 2015-2018. In addition to the generally accepted research methods, the patients underwent: 1) the determination of indicators of innate and acquired immune response in the blood (CD3+ -, CD3+ CD4+-, CD3+CD8+-, CD4+CD25+-, CD95+-, CD20+-, CD14+CD282+-, CD14+CD284+- cells; levels of IgG, IgA, IgM, circulating immune complexes, C3, C4) and urine (levels of IgG, IgA, IgM, C3, C4); 2) the determination of the levels of cytokines - IL-1β, Ra-IL-1β, IL-2, IL-4, IL-8, IL-10, IL-17A in blood serum and urine. The data obtained were compared with those of the group of healthy individuals. The changes in blood immunological parameters, identified in the group of patients with PIGN, indicate the activation of innate immunity (the increase in the number of CD14+TLR2+- cells) and the humoral component of adaptive immunity (the increase in the number of B-lymphocytes, hyperimmunoglobulinemia - the increase in IgM and IgA levels) against the background of the decrease in the number of T (CD3+) - lymphocytes and regulatory (CD4+CD25high) - cells, hypocomplementemia (decreased levels of C3, C4). The increase in the content of C3, IgG and IgA was found in the urine. The cytokine profile of blood in patients with PIGN was characterized by the increase in the levels of pro- and anti-inflammatory cytokines IL-1β, Ra-IL-1β, IL-2, IL-8, IL-10, IL-17A, with the exception of IL-4, which remained on the levels of healthy individuals. The cytokine profile of urine in patients was characterized by the increase in the levels of pro-inflammatory cytokines IL-1β, IL-2, IL-8, IL-17A and anti-inflammatory cytokine - IL-10, with no changes in the content of Ra-IL-1β and IL-4. The revealed features of the immunological profile of blood and urine in patients with PIGN reflect the immunopathogenetic mechanisms of this disease.
- 30 September 2021
- Published by I.N. Ulianov Chuvash State University in Acta medica Eurasica
- No. 3,p. 60-68
MODERN APPROACHES TO THE DIAGNOSIS AND THERAPY OF ALLERGIC DISEASES
Currently, great efforts are being made to optimize diagnostic and therapeutic standards in allergology. The introduction of biological drugs (omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab) into clinical practice increases the need for biomarkers of allergic diseases that make it possible to adequately choose a treatment regimen, determine the duration of therapy with expensive biopreparations. The article discusses the possibilities of using biomarkers developed in recent years thanks to the so-called "omics" technologies in clinical practice. Biomarkers used for the diagnosis and treatment of bronchial asthma, atopic dermatitis, allergic rhinitis, food allergies, hypersensitivity to drugs, as well as for evaluating the effectiveness of allergen – specific immunotherapy are considered. The introduction of biomarkers into clinical practice has made it possible to carry out endotyping of some allergic diseases, which opens up prospects for new approaches to classification of these diseases, development of individual treatment targets and indications for administering personalized therapy. Endotyping of diseases is expected to be transferred to the category of diagnostic tests. However, it is necessary to overcome a number of problems before the treatment based on endotype determination will be introduced into everyday practice in allergic diseases and bronchial asthma. Currently, most of the research on the endotyping of diseases is carried out in severe forms of allergic diseases. It is beyond argument that the best ways to treat allergic diseases will be found in the near future, with a therapeutic approach focused on a specific patient, taking into account the patient's wishes, the presence of contraindications, the psychological characteristics of the patient, his expected adherence to therapy and possible side effects.
- 30 September 2021
- Published by I.N. Ulianov Chuvash State University in Acta medica Eurasica
- No. 3,p. 60-68
MODERN APPROACHES TO THE DIAGNOSIS AND THERAPY OF ALLERGIC DISEASES
Currently, great efforts are being made to optimize diagnostic and therapeutic standards in allergology. The introduction of biological drugs (omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab) into clinical practice increases the need for biomarkers of allergic diseases that make it possible to adequately choose a treatment regimen, determine the duration of therapy with expensive biopreparations. The article discusses the possibilities of using biomarkers developed in recent years thanks to the so-called "omics" technologies in clinical practice. Biomarkers used for the diagnosis and treatment of bronchial asthma, atopic dermatitis, allergic rhinitis, food allergies, hypersensitivity to drugs, as well as for evaluating the effectiveness of allergen – specific immunotherapy are considered. The introduction of biomarkers into clinical practice has made it possible to carry out endotyping of some allergic diseases, which opens up prospects for new approaches to classification of these diseases, development of individual treatment targets and indications for administering personalized therapy. Endotyping of diseases is expected to be transferred to the category of diagnostic tests. However, it is necessary to overcome a number of problems before the treatment based on endotype determination will be introduced into everyday practice in allergic diseases and bronchial asthma. Currently, most of the research on the endotyping of diseases is carried out in severe forms of allergic diseases. It is beyond argument that the best ways to treat allergic diseases will be found in the near future, with a therapeutic approach focused on a specific patient, taking into account the patient's wishes, the presence of contraindications, the psychological characteristics of the patient, his expected adherence to therapy and possible side effects.
- Open Access
- 3 May 2021
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 23 (2) , 353-368
Republican registry of primary immune deficiencies in the chuvash republic and description of postvaccinal immunity disorders in a pregnant patient with common variable immune deficiency
In recent years, primary immunodeficiencies have turned from the class of rare diseases to the category of more common disorders which may be encountered by doctors of any clinical discipline. The first case of primary immunodeficiency disorder (PID) in Chuvashia was detected in 1993. Since that time, the Department of Internal Diseases with the Course of Clinical Immunology at the I. Ulyanov Chuvash State University registered all the cases of PID diagnosed in the region, introducing them into the Republican Registry of PID. The study was aimed for searching epidemiological indexes, clinical and laboratory manifestations of PID in Chuvash region. The study was based on the patient data obtained by retrospective analysis of 85 case histories of PID patients, treated at different departments of the Republican Clinical Hospital, and the City Chuvash Pediatric Clinical Hospital of Public Health Ministry in 2000-2019, as well as on 49 outpatient records of the patients included into the Regional PID Registry. Various forms of PIDs were diagnosed according to the criteria developed by the European Society for Immunodeficiency and the Pan-American Group on Immunodeficiency (1999). The results of this study showed that the incidence of PID in the Chuivash Region is 3.4:100,000. The incidence of common variable immune deficiency (CVID), the most common form of PID in the region, was 1.58 per 100,000 population. The average age at the time of CVID diagnosis in Chuvash patients was 30.4±16.1 years, and the age of CVID debut was 11.3±15.0 years. The delay in proper diagnosis from the moment of clinical manifestation of CVID was, on average, 17.9 years in the region. At the time of CVID diagnosis, the patients showed marked decrease in the levels of 3 or 2 immunoglobulin classes (IgG and IgA), and T-helper cell contents (CD3+CD4+) in peripheral blood. Prevalence of selective IgA deficiency with сlinical symptoms was 0.83 per 100,000 population of the region, and the incidence of the asymptomatic form of this PID was 1 : 167. In patients with selective IgA deficiency, there were also disorders in the T cell system manifesting as decreased relative number of cytotoxic T-cells as well as elevated IgG and IgM levels. The age of diagnosis of X-linked agammaglobulinemia in the region was 3.5±3.0 years. In addition to disturbances of humoral adaptive immunity in children with this disease, a decrease in absolute T cell numbers was detected. In conclusion, the article describes disturbances of postvaccinal immunity in a pregnant patient with CVID, with asymptomatic clinical course, thus leading to false interpretation of the serological markers of TORCH infections and wrong strategy of pregnancy management.
- 3 May 2021
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 23 (2) , 353-368
Open AccessRepublican registry of primary immune deficiencies in the chuvash republic and description of postvaccinal immunity disorders in a pregnant patient with common variable immune deficiency
In recent years, primary immunodeficiencies have turned from the class of rare diseases to the category of more common disorders which may be encountered by doctors of any clinical discipline. The first case of primary immunodeficiency disorder (PID) in Chuvashia was detected in 1993. Since that time, the Department of Internal Diseases with the Course of Clinical Immunology at the I. Ulyanov Chuvash State University registered all the cases of PID diagnosed in the region, introducing them into the Republican Registry of PID. The study was aimed for searching epidemiological indexes, clinical and laboratory manifestations of PID in Chuvash region. The study was based on the patient data obtained by retrospective analysis of 85 case histories of PID patients, treated at different departments of the Republican Clinical Hospital, and the City Chuvash Pediatric Clinical Hospital of Public Health Ministry in 2000-2019, as well as on 49 outpatient records of the patients included into the Regional PID Registry. Various forms of PIDs were diagnosed according to the criteria developed by the European Society for Immunodeficiency and the Pan-American Group on Immunodeficiency (1999). The results of this study showed that the incidence of PID in the Chuivash Region is 3.4:100,000. The incidence of common variable immune deficiency (CVID), the most common form of PID in the region, was 1.58 per 100,000 population. The average age at the time of CVID diagnosis in Chuvash patients was 30.4±16.1 years, and the age of CVID debut was 11.3±15.0 years. The delay in proper diagnosis from the moment of clinical manifestation of CVID was, on average, 17.9 years in the region. At the time of CVID diagnosis, the patients showed marked decrease in the levels of 3 or 2 immunoglobulin classes (IgG and IgA), and T-helper cell contents (CD3+CD4+) in peripheral blood. Prevalence of selective IgA deficiency with сlinical symptoms was 0.83 per 100,000 population of the region, and the incidence of the asymptomatic form of this PID was 1 : 167. In patients with selective IgA deficiency, there were also disorders in the T cell system manifesting as decreased relative number of cytotoxic T-cells as well as elevated IgG and IgM levels. The age of diagnosis of X-linked agammaglobulinemia in the region was 3.5±3.0 years. In addition to disturbances of humoral adaptive immunity in children with this disease, a decrease in absolute T cell numbers was detected. In conclusion, the article describes disturbances of postvaccinal immunity in a pregnant patient with CVID, with asymptomatic clinical course, thus leading to false interpretation of the serological markers of TORCH infections and wrong strategy of pregnancy management.
- Open Access
- 30 August 2020
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 66 (2) , 13-23
About connection of clinical manifestations of glomerulonephritis with features of the thyroid status of patients
BACKGROUND: There are four clinical variants of glomerulonephritis (GN) - urinary (latent), hypertensive, nephrotic and mixed. It was found that the features of clinical manifestations of GN that determine its clinical variant do not depend on the etiology, pathogenesis and morphological form of the disease. Taking into account the obtained data on the association of nephrotic syndrome with hypofunction of the thyroid gland, we suggested, that the formation of clinical variants of GN may be influenced by the features of the thyroid status of patients. AIM: Study the relationship of variants of clinical manifestations of GN with indicants of thyroid status. MATERIALS AND METHODS: The study included patients with primary GN who received in-treatment in the nephrology unit of a general hospital. Patients were selected into 4 groups depending on the clinical variant of GN (urinary, nephrotic, hypertensive and mixed variants). When selecting patients, we achieved comparability of groups by age, gender, morphological variants and duration of the disease. In addition to the generally accepted methods of research, patients were performed: 1) assessment of the thyroid status (thyroid-stimulating hormone (TSH), free thyroxine (free T4), free triiodothyronine (free T3), antibodies to thyroperoxidase (anti-TPO), (free T3+free T4)/TSH, free T4/free T3, free T4/TSH); 2) determination of levels of interleukin - IL-1, IL-4 and IL-10 in blood serum; 3) ultrasound (US) examination of the thyroid gland. The obtained data were compared with those of healthy people. RESULTS: The group of patients with the nephrotic variant of GN in 50% of cases showed a decrease of the level of free Т4 with the increase of TSH level, 26.7% showed a moderate increase of TSH at unchanged concentrations of free Т4 and free T3. In patients with the urinary variant of GN, the thyroid status did not differ from that in healthy patients, and the cytokine profile was characterized by a simultaneous increase in the content of the proinflammatory cytokine IL-1 and the anti-inflammatory cytokine IL-10. The group of patients with the hypertonic variant of GN in 82% of cases showed an isolated increase in TSH content. In the group of patients with a mixed variant of GN, changes in thyroid indices were predominant, combined with a large variability in the level of IL-1 production. CONCLUSIONS: The results of the study indicate the influence of the functional state of the pituitary-thyroid system on the formation of different clinical variants of GN, which depends mainly on the level of production of the anti-inflammatory cytokine IL-10.
- 30 August 2020
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 66 (2) , 13-23
Open AccessAbout connection of clinical manifestations of glomerulonephritis with features of the thyroid status of patients
BACKGROUND: There are four clinical variants of glomerulonephritis (GN) - urinary (latent), hypertensive, nephrotic and mixed. It was found that the features of clinical manifestations of GN that determine its clinical variant do not depend on the etiology, pathogenesis and morphological form of the disease. Taking into account the obtained data on the association of nephrotic syndrome with hypofunction of the thyroid gland, we suggested, that the formation of clinical variants of GN may be influenced by the features of the thyroid status of patients. AIM: Study the relationship of variants of clinical manifestations of GN with indicants of thyroid status. MATERIALS AND METHODS: The study included patients with primary GN who received in-treatment in the nephrology unit of a general hospital. Patients were selected into 4 groups depending on the clinical variant of GN (urinary, nephrotic, hypertensive and mixed variants). When selecting patients, we achieved comparability of groups by age, gender, morphological variants and duration of the disease. In addition to the generally accepted methods of research, patients were performed: 1) assessment of the thyroid status (thyroid-stimulating hormone (TSH), free thyroxine (free T4), free triiodothyronine (free T3), antibodies to thyroperoxidase (anti-TPO), (free T3+free T4)/TSH, free T4/free T3, free T4/TSH); 2) determination of levels of interleukin - IL-1, IL-4 and IL-10 in blood serum; 3) ultrasound (US) examination of the thyroid gland. The obtained data were compared with those of healthy people. RESULTS: The group of patients with the nephrotic variant of GN in 50% of cases showed a decrease of the level of free Т4 with the increase of TSH level, 26.7% showed a moderate increase of TSH at unchanged concentrations of free Т4 and free T3. In patients with the urinary variant of GN, the thyroid status did not differ from that in healthy patients, and the cytokine profile was characterized by a simultaneous increase in the content of the proinflammatory cytokine IL-1 and the anti-inflammatory cytokine IL-10. The group of patients with the hypertonic variant of GN in 82% of cases showed an isolated increase in TSH content. In the group of patients with a mixed variant of GN, changes in thyroid indices were predominant, combined with a large variability in the level of IL-1 production. CONCLUSIONS: The results of the study indicate the influence of the functional state of the pituitary-thyroid system on the formation of different clinical variants of GN, which depends mainly on the level of production of the anti-inflammatory cytokine IL-10.